查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600197

预填充式注射器市场：按设计、产品类型、治疗方法、应用划分 - 2025-2030 年全球预测

Prefilled Syringes Market by Design, Product Type, Therapeutic, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年预填充式注射器市场规模为139.2亿美元，预计2024年将达到149.1亿美元，复合年增长率为7.63%，2030年将达232.9亿美元。

预填充式注射器市场是製药和医疗保健产业中一个快速成长的领域，其定义是使用预充有特定剂量以便于给药的注射器。该市场是由更有效率、更安全、更方便地输送注射药物（特别是疫苗、生技药品和急救药物）的需求所推动的。预填充式注射器在肿瘤学、糖尿病和心血管疾病等治疗领域有着重要的应用，同时因降低污染风险和精确的药物传递而受到青睐。生技药品的进步和患者对自我给药的偏好的增加正在推动对预填充式注射器的需求。关键的成长要素包括慢性病的增加、生物製药行业的扩张以及以患者为中心的医疗保健解决方案日益增长的需求。市场机会主要存在于解决生物製药复杂性的双腔室和自动注射器等创新中。挑战包括注射器与多种生技药品的兼容性以及潜在的监管障碍。这些因素需要加强材料科学的研究，以开发与更精緻的药物相容的注射器，同时保持无菌和完整性。此外，人们越来越关注永续性，并鼓励环保材料和可回收组件的创新，以减少对环境的影响。该市场竞争激烈，成熟的製药公司和专业生物技术公司共同推动市场。为了利用新的商机，公司应投资于更具永续和生物相容性的注射器设计的研发，并加强新兴市场销售管道的策略伙伴关係。不断将患者回馈纳入产品开发有助于确保符合不断变化的医疗保健需求和监管标准。

主要市场统计
基准年[2023] 139.2亿美元
预测年份 [2024] 149.1亿美元
预测年份 [2030] 232.9亿美元
复合年增长率（%） 7.63%

市场动态：揭示快速发展的预填充式注射器市场的关键市场洞察

供需的动态交互作用正在改变预填充式注射器市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 自我护理设备的普及数位化的进步
    • 学名药快速成长
    • 增加支出以开发高效的医疗基础设施
  • 市场限制因素
    • 缺乏具有整合安全功能的预填充式注射器
  • 市场机会
    • 新兴国家医疗保健基础设施的成长
    • 更多采用穿戴式药物传输技术
  • 市场挑战
    • 具有成本效益的替代方案的可用性

波特五力：驾驭预填充式注射器市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解预填充式注射器市场的外部影响

外部宏观环境因素在塑造预填充式注射器市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解预填充式注射器市场的竞争状况

对预填充式注射器市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵预填充式注射器市场供应商绩效评估

FPNV定位矩阵是评估预填充式注射器市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了预填充式注射器市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，预填充式注射器市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 扩大自我护理设备和数数位化的引进
      • 学名药快速成长
      • 增加开发高效能医疗基础设施的支出
    • 抑制因素
      • 缺乏具有整合安全功能的预填充式注射器
    • 机会
      • 扩大新兴国家的医疗基础设施
      • 更多采用穿戴式药物传输技术
    • 任务
      • 具有成本效益的替代方案的可用性
  • 市场区隔分析
    • 治疗类别：扩大预填充式注射器在不同类别中的使用，强调了它们在促进更好的治疗结果方面的作用。
    • 应用：适用于各种医疗状况的预填充式注射器对于了解市场潜力和成长动力至关重要。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章预填充式注射器市场：设计

  • 客製化预填充式注射器
  • 双腔室预填充式注射器
  • 单室预填充式注射器

第七章预填充式注射器市场：依产品类型

  • 玻璃预灌封注射器
  • 塑胶预灌封注射器

第八章预填充式注射器市场治疗

  • 用于关节炎的预填充式注射器
  • 肝素填充注射器
  • 胰岛素预填充式注射器
  • PCSK9抑制剂预填充式注射器
  • 疫苗预灌封注射器

第九章预填充式注射器市场：依应用分类

  • 过敏反应
  • 癌症
  • 糖尿病
  • 眼科
  • 类风湿性关节炎
  • 血栓症

第十章 北美和南美预填充式注射器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太预填充式注射器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲预填充式注射器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Bora Pharmaceuticals 收购 Emergent BioSolutions 的巴尔的摩工厂，以扩大北美业务并加强预填充式注射器生产
    • Schott Pharma 与 Col Medical Systems 合作，透过创新的预填充式注射器解决方案增强生物製药药物输送和市场占有率
    • ROVI 透过专注于便利性、安全性和永续性的新预填充式注射器製造协议提高了市场占有率和收益。
    • 肖特製药扩大美国业务，透过新的预填充式注射器工厂提高产能和市场渗透率
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • AptarGroup, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Catalent, Inc. by Novo Holdings A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • Mylan NV by Viatris Inc.
  • Nipro Europe Group Companies
  • Novartis AG
  • Pfizer, Inc.
  • Samsung Bioepis
  • Sanofi
  • SCHOTT Pharma
  • Shandong Weigao Group Medical Polymer Company Limited
  • SHL Medical AG
  • Stevanato Group
  • Terumo Medical Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
Product Code: MRR-030EE48515C9

The Prefilled Syringes Market was valued at USD 13.92 billion in 2023, expected to reach USD 14.91 billion in 2024, and is projected to grow at a CAGR of 7.63%, to USD 23.29 billion by 2030.

The prefilled syringes market is a rapidly growing segment within the pharmaceutical and healthcare industry, defined by the use of syringes that are pre-packed with a specific dosage of medication, allowing for easy administration. This market is driven by the necessity for more efficient, safe, and convenient delivery of injectable drugs, particularly vaccines, biologics, and emergency medications. Prefilled syringes find critical applications in therapeutic areas such as oncology, diabetes, and cardiovascular diseases, while also being favored for their reduced risk of contamination and precise drug delivery. Advances in biologics and a rising preference for self-administration among patients propel the demand for prefilled syringes. Key growth factors include the increasing number of chronic diseases, expanding biopharmaceutical sector, and mounting need for patient-centric healthcare solutions. Market opportunities are present in technological innovations like dual-chamber and auto-injectable syringes, predominantly addressing the complexities of biologic drug formulations. Limitations include challenges in achieving syringe compatibility with a wide range of biologics and potential regulatory hurdles. These factors necessitate enhanced research in materials science to develop syringes that are more compatible with sensitive drugs while maintaining sterility and integrity. Furthermore, sustainability is a growing concern, recommending innovations in eco-friendly materials and recyclable components to mitigate environmental impact. The nature of the market is progressively competitive, driven by both established pharmaceutical companies and specialized biotech firms. To capitalize on emerging opportunities, businesses should invest in R&D for more sustainable and biocompatible syringe designs and strengthen strategic partnerships for distribution channels in emerging markets. Continuous patient feedback integration into product development can ensure better adherence to evolving healthcare demands and regulatory standards.

KEY MARKET STATISTICS
Base Year [2023] USD 13.92 billion
Estimated Year [2024] USD 14.91 billion
Forecast Year [2030] USD 23.29 billion
CAGR (%) 7.63%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Prefilled Syringes Market

The Prefilled Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing adoption of self-care devices and digitalization
    • Rapid growth in generic products
    • Rising expenditure on development of efficient healthcare infrastructure
  • Market Restraints
    • Dearth of prefilled syringes with integrated safety features
  • Market Opportunities
    • Growing healthcare infrastructure across emerging countries
    • Increasing adoption of wearable drug delivery technologies
  • Market Challenges
    • Availability of cost effective alternatives

Porter's Five Forces: A Strategic Tool for Navigating the Prefilled Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Prefilled Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Prefilled Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Prefilled Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Prefilled Syringes Market

A detailed market share analysis in the Prefilled Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Prefilled Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Prefilled Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Prefilled Syringes Market

A strategic analysis of the Prefilled Syringes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Prefilled Syringes Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AptarGroup, Inc., Baxter International, Inc., Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Gerresheimer AG, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. by Johnson & Johnson, Mylan N.V. by Viatris Inc., Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., Samsung Bioepis, Sanofi, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Prefilled Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Design, market is studied across Customized Prefilled Syringes, Dual-Chamber Prefilled Syringes, and Single-Chamber Prefilled Syringes.
  • Based on Product Type, market is studied across Glass Pre Filled Syringes and Plastic Pre Filled Syringes.
  • Based on Therapeutic, market is studied across Arthritis Pre Filled Syringes, Heparin Pre Filled Syringes, Insulin Pre Filled Syringes, PCSK9 Inhibitor Pre Filled Syringes, and Vaccine Pre Filled Syringes.
  • Based on Application, market is studied across Anaphylaxis, Cancer, Diabetes, Ophthalmology, Rheumatoid Arthritis, and Thrombosis.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing adoption of self-care devices and digitalization
      • 5.1.1.2. Rapid growth in generic products
      • 5.1.1.3. Rising expenditure on development of efficient healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. Dearth of prefilled syringes with integrated safety features
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing healthcare infrastructure across emerging countries
      • 5.1.3.2. Increasing adoption of wearable drug delivery technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of cost effective alternatives
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Therapeutic Category: Expanding use of prefilled syringes across various categories underscores their role in fostering better therapeutic outcomes
    • 5.2.2. Application: Prefilled syringes across various medical conditions is vital to understanding their market potential and growth drivers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Prefilled Syringes Market, by Design

  • 6.1. Introduction
  • 6.2. Customized Prefilled Syringes
  • 6.3. Dual-Chamber Prefilled Syringes
  • 6.4. Single-Chamber Prefilled Syringes

7. Prefilled Syringes Market, by Product Type

  • 7.1. Introduction
  • 7.2. Glass Pre Filled Syringes
  • 7.3. Plastic Pre Filled Syringes

8. Prefilled Syringes Market, by Therapeutic

  • 8.1. Introduction
  • 8.2. Arthritis Pre Filled Syringes
  • 8.3. Heparin Pre Filled Syringes
  • 8.4. Insulin Pre Filled Syringes
  • 8.5. PCSK9 Inhibitor Pre Filled Syringes
  • 8.6. Vaccine Pre Filled Syringes

9. Prefilled Syringes Market, by Application

  • 9.1. Introduction
  • 9.2. Anaphylaxis
  • 9.3. Cancer
  • 9.4. Diabetes
  • 9.5. Ophthalmology
  • 9.6. Rheumatoid Arthritis
  • 9.7. Thrombosis

10. Americas Prefilled Syringes Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Prefilled Syringes Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Prefilled Syringes Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Bora Pharmaceuticals acquires Baltimore facility from Emergent BioSolutions to expand North American footprint and enhance prefilled syringe production
    • 13.3.2. SCHOTT Pharma and Koru Medical Systems partner to enhance drug delivery, market share in biologics with innovative prefilled syringe solutions
    • 13.3.3. ROVI to enhance market presence and revenue with new pre-filled syringe manufacturing agreement, focusing on convenience, safety, and sustainability
    • 13.3.4. Schott Pharma expands U.S. operations with new prefillable syringe facility boosting production capacity and market penetration
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AptarGroup, Inc.
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Boehringer Ingelheim Pharmaceuticals, Inc
  • 6. Catalent, Inc. by Novo Holdings A/S
  • 7. Eli Lilly and Company
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Fresenius Kabi AG
  • 10. Gerresheimer AG
  • 11. GlaxoSmithKline plc
  • 12. Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • 13. Mylan N.V. by Viatris Inc.
  • 14. Nipro Europe Group Companies
  • 15. Novartis AG
  • 16. Pfizer, Inc.
  • 17. Samsung Bioepis
  • 18. Sanofi
  • 19. SCHOTT Pharma
  • 20. Shandong Weigao Group Medical Polymer Company Limited
  • 21. SHL Medical AG
  • 22. Stevanato Group
  • 23. Terumo Medical Corporation
  • 24. Teva Pharmaceutical Industries Ltd.
  • 25. West Pharmaceutical Services, Inc.
  • 26. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. PREFILLED SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 2. PREFILLED SYRINGES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PREFILLED SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PREFILLED SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CUSTOMIZED PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GLASS PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ARTHRITIS PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY HEPARIN PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY INSULIN PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PCSK9 INHIBITOR PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VACCINE PRE FILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 196. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023